peptide
Melanotan I (afamelanotide) tracker
Educational reference for Melanotan I (afamelanotide). Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
15 h
Tmax
36 h
Category
peptide
Also known as: afamelanotide, scenesse, mt-1, mt1, nle4-d-phe7-alpha-msh
Melanotan I is afamelanotide, an alpha-MSH analogue with one FDA-approved implant product.
Mechanism
A synthetic analogue of alpha-melanocyte-stimulating hormone that acts mainly at the melanocortin-1 receptor.
Research summary
Afamelanotide (Scenesse) is an FDA-approved implant for erythropoietic protoporphyria. Injectable melanotan products sold online are not approved. Melanotan I and melanotan II are different molecules.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Scenesse (afamelanotide) prescribing information · FDA prescribing informationApparent half-life about 15 h after implant administration, with median Tmax around 36 h. This is an apparent value for a controlled-release implant and may not apply to other formulations.
A TrackPep egy naplózó alkalmazás. Azt rögzíti, amit megadsz, és soha nem javasol vagy számít ki mennyiségeket.